Jay Aldrich doesn’t spend a lot of time thinking about his spinal cord stimulator, and that’s one thing he loves about it.

Not only has it brought him relief from the chronic back pain that he couldn’t find through physical therapy, medications, and other pain treatments, but his device doesn’t have to be recharged.

Spinal cord stimulation provides effective pain relief by blocking the pain signals between the spinal cord and brain. But many spinal cord stimulators need to be recharged regularly.

“Recharging would be little bit burdensome for me,” said Aldrich, 74, who received the Vanta™, a recharge-free spinal cord stimulator from Medtronic earlier this year. “When I go to sleep at night, I don’t have to worry or stress about forgetting to recharge the device which is great.”

In 2013, Jay fell on the ice in his driveway, beginning a long journey with chronic back pain. He tried exercise, physical therapy, epidurals, and other pain treatments suggested by his doctor, but none worked.

Desperate for pain relief, he participated in a seven-day trial and then surgery to implant the Vanta™ spinal cord stimulator.

Finding personalized relief

With its extended battery performance, Vanta™ is designed to offer patients like Jay an estimated 5.5 to 7.5 years of pain relief without having to recharge the device.

Vanta™ also personalizes Jay’s pain relief. It adapts to Jay’s movement or body position using a built-in accelerometer and modifies his therapy accordingly. Jay credits the device with relieving much of his pain.

“Vanta™ has truly been a life-changer for me,” said Jay, who has returned to enjoying outdoor activities, including biking and gardening. “It has allowed me the freedom of travel without having to carry a rechargeable system with me.”

A device for the family

Jay’s journey to pain relief even inspired his wife Sandra, who also suffered from chronic back pain resulting from an injury many years earlier.

Though multiple medical treatments failed to relieve her pain, Sandra was reluctant to undergo surgery and have a spinal cord stimulation device implanted.

After seeing the difference the device made in her husband’s pain, Sandra consulted her doctor and underwent a successful seven-day trial of Vanta™.

“Once they put it in, I said to myself, ‘this is a gift,’” said Sandra, who had the device implanted a few weeks later.

Today, the couple credits their spinal cord stimulators with allowing them to return to hiking the trails of the Great Smoky Mountains National Park, where they serve as volunteers.

But perhaps the greatest benefit is the improved quality of time spent with family.

“To be able to pick up our young grandson, that means everything,” said Sandra. “The future is so awesomely bright because we get to do things that we love and do it together, and I know it sounds corny, but to grow old together happily.”

 

SPINAL CORD STIMULATION BRIEF SUMMARY

INDICATIONS Spinal cord stimulation (SCS) is indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs-including unilateral or bilateral pain. CONTRAINDICATIONS Diathermy - Energy from diathermy can be transferred through the implanted system and cause tissue damage resulting in severe injury or death. WARNINGS Sources of electromagnetic interference (e.g., defibrillation, electrocautery, MRI, RF ablation, and therapeutic ultrasound) can interact with the system, resulting in unexpected changes in stimulation, serious patient injury or death. An implanted cardiac device (e.g., pacemaker, defibrillator) may damage a neurostimulator, and electrical pulses from the neurostimulator may cause inappropriate response of the cardiac device. Patients with diabetes may have more frequent and severe complications with surgery. A preoperative assessment is advised for some patients with diabetes to confirm they are appropriate candidates for surgery. PRECAUTIONS Safety and effectiveness has not been established for pediatric use, pregnancy, unborn fetus, or delivery. Avoid activities that put stress on the implanted neurostimulation system components. Recharging a rechargeable neurostimulator may result in skin irritation or redness near the implant site. ADVERSE EVENTS May include: undesirable change in stimulation (uncomfortable, jolting or shocking); hematoma, epidural hemorrhage, paralysis, seroma, infection, erosion, device malfunction or migration, pain at implant site, loss of pain relief, and other surgical risks. Adverse events may result in fluctuations in blood glucose in patients with diabetes. Refer to www.medtronic.com for product manuals for complete indications, contraindications, warnings, precautions and potential adverse events. Rx only. Rev 0422

UC202304687EN

 

L00109012022